(Q44004417)

28 November 2017

title

LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy (English)

1 reference

28 November 2017

Petit JM

1

1 reference

28 November 2017

Duong M

2

1 reference

28 November 2017

Duvillard L

3

1 reference

28 November 2017

Florentin E

4

1 reference

28 November 2017

Portier H

5

1 reference

28 November 2017

Lizard G

6

1 reference

28 November 2017

Brun JM

7

1 reference

28 November 2017

Gambert P

8

1 reference

28 November 2017

Verges B

9

1 reference

28 November 2017

language of work or name

1 reference

1 May 2002

1 reference

European Journal of Clinical Investigation

28 November 2017

published in

1 reference

28 November 2017

volume

32

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

354-359

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneoplastic liver nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

HIV protease inhibitors stimulate hepatic triglyceride synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2002.00989.X

10.1046/J.1365-2362.2002.00989.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference